Skip to main content
Bianca Santomasso, MD, Neurology, New York, NY, Memorial Sloan Kettering Cancer Center

BiancaDeniseSantomassoMD

Neurology New York, NY

Neurooncology

Assistant Attending

Overview of Dr. Santomasso

Dr. Bianca Santomasso is a neurologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from Weill Cornell Medicine and has been in practice 9 years. She is one of 57 doctors at Memorial Sloan Kettering Cancer Center who specialize in Neurology. She has more than 50 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2009 - 2013
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2008

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2020 - 2025
  • NY State Medical License
    NY State Medical License 2013 - 2024
  • American Board of Psychiatry and Neurology Neurology
  • UCNSNeuro-Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Hematological Count Recovery in Patients Undergoing Treatment with Chimeric Antigen Receptor T Cells (CAR T)
    Bianca Santomasso, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T Cells
    Bianca Santomasso, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Comparing Gradings of Immune Effector Cells Toxicities: Application of Astct Consensus Grading System and Implications for Clinical Management
    Bianca Santomasso, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Neurotoxicity From CAR T-Cell Therapy: Why It Happens, How to Manage It, and Who Is at Risk? 
    ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
  • Neurologic immune related adverse events (irAEs) in patients treated with immune checkpoint blockade. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Incysus Announces Formation of Scientific Advisory Board
    Incysus Announces Formation of Scientific Advisory BoardAugust 24th, 2017
  • Incysus Announces Appointment of Siraj Ali, MD, PhD to Its Scientific Advisory Board
    Incysus Announces Appointment of Siraj Ali, MD, PhD to Its Scientific Advisory BoardJanuary 12th, 2017

Hospital Affiliations